Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
7.03
-0.76 (-9.76%)
At close: Sep 11, 2024, 4:00 PM
7.30
+0.27 (3.84%)
After-hours: Sep 11, 2024, 4:52 PM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $166.30 million as of September 11, 2024. Its market cap has decreased by -44.92% in one year.
Market Cap
166.30M
Enterprise Value
167.00M
1-Year Change
-44.92%
Ranking
Category
Stock Price
$7.03
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has increased from $97.40M to $166.30M, an increase of 70.74%. That is a compound annual growth rate of 6.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2024 | 184.30M | 79.80% |
| Dec 29, 2023 | 102.50M | -58.42% |
| Dec 30, 2022 | 246.50M | -19.18% |
| Dec 31, 2021 | 305.00M | 84.51% |
| Dec 31, 2020 | 165.30M | 828.65% |
| Dec 31, 2019 | 17.80M | -58.12% |
| Dec 31, 2018 | 42.50M | 28.01% |
| Dec 29, 2017 | 33.20M | -53.24% |
| Dec 30, 2016 | 71.00M | -27.10% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 194.85M |
| Skye Bioscience | 192.65M |
| biote | 191.54M |
| Tenaya Therapeutics | 190.12M |
| Greenwich LifeSciences | 189.55M |
| Stereotaxis | 186.92M |
| Codexis | 185.83M |
| Mersana Therapeutics | 184.01M |